A detailed history of Caitong International Asset Management Co., LTD transactions in Geron Corp stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 58,863 shares of GERN stock, worth $150,689. This represents 0.2% of its overall portfolio holdings.

Number of Shares
58,863
Previous 58,863 -0.0%
Holding current value
$150,689
Previous $208 Million -0.0%
% of portfolio
0.2%
Previous 0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.3 - $4.44 $194,247 - $261,351
58,863 New
58,863 $208 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $967M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.